Categories: News

OrthoPediatrics Corp. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

WARSAW, Ind., Feb. 11, 2021 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President, Fred Hite, Chief Operating Officer and Chief Financial Officer, and Mark Throdahl, Chief Executive Officer, are scheduled to participate in a fireside chat at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Thursday, February 18, 2021.

Event: BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Format: Fireside Chat and One-on-One Meetings
Date: Thursday, February 18, 2021
Location: Virtual
Time: 10:00am ET

An audio webcast of the presentation will be available online at OrthoPediatrics’ investor relations website, http://ir.orthopediatrics.com.

Investors participating in the conference who would like to schedule a one-on-one call with OrthoPediatrics management may do so by contacting their BTIG representative, or James Salierno of The Ruth Group at jsalierno@theruthgroup.com.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 35 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 43 countries outside the United States. For more information, please visit www.orthopediatrics.com.

Investor Contact
The Ruth Group
James Salierno
(646) 536-7028
jsalierno@theruthgroup.com

Staff

Recent Posts

Optimind Pharma – Private Placement

Toronto, Ontario--(Newsfile Corp. - July 3, 2024) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind"…

31 mins ago

Veterinarians Moonlight as Bartenders for a Cause

VRCCO veterinarians serve beer at Ponch's Place for "Meet the Vet" nightsBEND, OR / ACCESSWIRE…

3 hours ago

Evive Brands Continues Q2 Steady Growth with 12 New Franchise Agreements

SCOTTSDALE, Ariz., July 3, 2024 /PRNewswire/ -- Evive Brands, a leader in the health and…

6 hours ago

Operating Room Management Market: Transforming Healthcare with USD 7.5 Billion Potential by 2029 | MarketsandMarkets™

CHICAGO, July 3, 2024 /PRNewswire/ -- The global operating room management market is poised to grow…

6 hours ago

Services PMI® at 48.8%; June 2024 Services ISM® Report On Business®

Business Activity Index at 49.6%; New Orders Index at 47.3%; Employment Index at 46.1%; Supplier…

6 hours ago